逆行胰胆管造影(ERCP)对胰胆疾病的治疗研究  

Retrograde cholangiopancreatography(ERCP) for the treatment of pancreatic biliary diseases

作　　者：洪慧玲[1] 

机构地区：[1]安徽省黄山市人民医院消化内科,安徽黄山245000

出　　处：《中国医药科学》2013年第21期116-117,共2页China Medicine And Pharmacy

摘　　要：目的研究逆行胰胆造影对胰胆疾病对疾病的诊断价值。方法回顾性分析我院2006年3月～2013年6月收治的胰胆管疾病患者102例，分析经逆行胆管造影以及MRI联合磁共振进行诊断所得资料，对比分析种诊断方法在临床中的诊断价值。结果逆行胆管造影法总符合率为97．06％，MRI联合磁共振法总符合率为99．02％。经比较，两种诊断方法在诊断符合率上差异无统计学意义（P〉O．05）。结论逆行胰胆管造影在临床中是胰胆疾病的金标准，具有决定性的临床意义，并且可以同时通过内镜进行治疗，是其他诊断技术所无法达到的优点，该法应在临床中继续推广。Objective To study retrograde biliary pancreatic biliary disease on angiography in the diagnosis of disease. Methods A retrospective analysis of our hospital from March 2006 to June 2013 were treated 102 patients with pancreatic duct diseases analyzed by combined retrograde eholangiopancreatography and MRI magnetic resonance diagnostic information obtained comparative analysis of species diagnostic methods in clinical diagnosis. Results Retrograde cholangiopancreatography France total coincidence rate 97.06%, MRI magnetic resonance method combined total coincidence rate 99.02%. By comparison,two diagnostic methods in the diagnosis rate on the difference was not statistically significant（P 〈 0.05）. Conclusion Retrograde cholangiopancreatography in clinical pancreatic biliary disease is the gold standard,with decisive clinical significance, and can be treated through endoscopy,other diagnostic techniques can not reach the merits of the law should continue to promote in the clinic.

关 键 词：逆行胆管造影 胰胆疾病 治疗研究 

分 类 号：R816.5[医药卫生—放射医学]